TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Aros Forskning & Friskvård AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
35
|
27
|
17 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
54
|
22
|
9 |
| EBITDA |
22
|
22
|
9 |
| Total assets |
82
|
68
|
53 |
| Current assets |
5
|
19
|
10 |
| Current liabilities |
9
|
7
|
3 |
| Equity capital |
73
|
61
|
49 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.0%
|
89.7%
|
92.5% |
| Turnover per employee |
35
|
27
|
17 |
| Profit as a percentage of turnover |
154.3%
|
81.5%
|
52.9% |
| Return on assets (ROA) |
65.9%
|
32.4%
|
17.0% |
| Current ratio |
55.6%
|
271.4%
|
333.3% |
| Return on equity (ROE) |
74.0%
|
36.1%
|
18.4% |
| Change turnover |
9
|
10
|
-5 |
| Change turnover % |
34%
|
58%
|
-22% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.